Related Experiment Videos
Systemic effects of chronic obstructive pulmonary disease
A G N Agustí1, A Noguera, J Sauleda
1Servei de Pneumología, Hospital Universitari Son Dureta, Palma de Mallorca, Spain. aagusti@hsd.es
The European Respiratory Journal
|March 1, 2003
Summary
Chronic obstructive pulmonary disease (COPD) involves lung inflammation from pollutants. This review explores COPD's systemic effects beyond the lungs, including inflammation, weight loss, and muscle dysfunction, impacting disease management.
Area of Science:
- Pulmonology
- Internal Medicine
- Pathophysiology
Background:
- Chronic obstructive pulmonary disease (COPD) is primarily characterized by lung inflammation due to environmental pollutants, predominantly tobacco smoke.
- Beyond its pulmonary manifestations like chronic bronchitis and emphysema, COPD is increasingly recognized for its systemic effects.
Purpose of the Study:
- To review the systemic effects of COPD, including systemic inflammation, nutritional abnormalities, weight loss, and skeletal muscle dysfunction.
- To discuss the potential mechanisms and clinical implications of these extra-pulmonary manifestations.
- To identify areas for future research in COPD systemic effects.
Main Methods:
- Literature review of studies investigating systemic effects in COPD patients.
- Analysis of mechanisms linking pulmonary and systemic pathology.
- Discussion of clinical relevance for disease classification and management.
Main Results:
- COPD is associated with significant systemic inflammation.
- Nutritional abnormalities and unintended weight loss are common in COPD patients.
- Skeletal muscle dysfunction is a key systemic feature of COPD.
- Other potential systemic effects warrant further investigation.
Conclusions:
- Systemic effects are integral to COPD, influencing its clinical presentation and progression.
- Understanding these effects is crucial for comprehensive COPD management and patient stratification.
- Further research is needed to elucidate mechanisms and optimize therapeutic strategies for systemic manifestations of COPD.